Page last updated: 2024-12-06
chlotazol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
chlotazol: for treatment of rheumatoid arthritis; condensation product of chloral hydrate & 2-aminothiazole [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 37113 |
SCHEMBL ID | 11525031 |
MeSH ID | M0105411 |
Synonyms (28)
Synonym |
---|
khlotazol |
nsc261134 |
35317-79-4 |
nsc-261134 |
trichloromethyl-(thiazoylamino(2))-methanol |
ethanol, 2,2,2-trichloro-1-(2-thiazolylamino)- |
2,2,2-trichlor-1-(2-thiazolylamino)-aethanol [german] |
ethanol, 1-(2-thiazolylamino)-2,2,2-trichloro- |
nsc 261134 |
chlotazole |
2,2,2-trichloro-1-(2-thiazolylamino)ethanol |
brn 0152089 |
clotazol |
STK324580 |
2,2,2-trichloro-1-(1,3-thiazol-2-ylamino)ethanol |
AKOS002324596 |
SCHEMBL11525031 |
82190-87-2 |
atizol |
chlotazol |
chlothazol |
2,2,2-trichlor-1-(2-thiazolylamino)-aethanol |
4-27-00-04586 (beilstein handbook reference) |
AKOS016327075 |
Q4498280 |
CS-0364883 |
2,2,2-trichloro-1-(thiazol-2-ylamino)ethan-1-ol |
DTXSID601031763 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (4)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.25
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.25) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |